Benralizumab, the first new treatment for asthma and chronic obstructive pulmonary disease (COPD), is being called a ‘game-changer’ by researchers. Initially reserved for severe cases, new studies suggest it may soon benefit more patients
Discover more from The Doon Mozaic
Subscribe to get the latest posts sent to your email.